Skip to main content
NCBI home page
Gut logoLink to Gut
. 1995 Jan;36(1):5–8. doi: 10.1136/gut.36.1.5

Platelet dysfunction: a new dimension in inflammatory bowel disease.

C E Collins 1, D S Rampton 1
PMCID: PMC1382343  PMID: 7890235

Full text

PDF
5

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ameisen J. C., Capron A., Joseph M., Maclouf J., Vorng H., Pancré V., Fournier E., Wallaert B., Tonnel A. B. Aspirin-sensitive asthma: abnormal platelet response to drugs inducing asthmatic attacks. Diagnostic and physiopathological implications. Int Arch Allergy Appl Immunol. 1985;78(4):438–448. doi: 10.1159/000233927. [DOI] [PubMed] [Google Scholar]
  2. BORN G. V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962 Jun 9;194:927–929. doi: 10.1038/194927b0. [DOI] [PubMed] [Google Scholar]
  3. Banerjee A. K., Peters T. J. Experimental non-steroidal anti-inflammatory drug-induced enteropathy in the rat: similarities to inflammatory bowel disease and effect of thromboxane synthetase inhibitors. Gut. 1990 Dec;31(12):1358–1364. doi: 10.1136/gut.31.12.1358. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  4. Berk B. C., Alexander R. W., Brock T. A., Gimbrone M. A., Jr, Webb R. C. Vasoconstriction: a new activity for platelet-derived growth factor. Science. 1986 Apr 4;232(4746):87–90. doi: 10.1126/science.3485309. [DOI] [PubMed] [Google Scholar]
  5. Boogaerts M. A., Yamada O., Jacob H. S., Moldow C. F. Enhancement of granulocyte-endothelial cell adherence and granulocyte-induced cytotoxicity by platelet release products. Proc Natl Acad Sci U S A. 1982 Nov;79(22):7019–7023. doi: 10.1073/pnas.79.22.7019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Boughton-Smith N. K., Hutcheson I., Whittle B. J. Relationship between PAF-acether and thromboxane A2 biosynthesis in endotoxin-induced intestinal damage in the rat. Prostaglandins. 1989 Sep;38(3):319–333. doi: 10.1016/0090-6980(89)90136-6. [DOI] [PubMed] [Google Scholar]
  7. Braquet P., Touqui L., Shen T. Y., Vargaftig B. B. Perspectives in platelet-activating factor research. Pharmacol Rev. 1987 Jun;39(2):97–145. [PubMed] [Google Scholar]
  8. Collins C. E., Cahill M. R., Newland A. C., Rampton D. S. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology. 1994 Apr;106(4):840–845. doi: 10.1016/0016-5085(94)90741-2. [DOI] [PubMed] [Google Scholar]
  9. Collins C. E., Cahill M. R., Rampton D. S. Clubbing in Crohn's disease. BMJ. 1993 Aug 21;307(6902):508–508. doi: 10.1136/bmj.307.6902.508-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Coëffier E., Delautier D., Le Couedic J. P., Chignard M., Denizot Y., Benveniste J. Cooperation between platelets and neutrophils for paf-acether (platelet-activating factor) formation. J Leukoc Biol. 1990 Mar;47(3):234–243. doi: 10.1002/jlb.47.3.234. [DOI] [PubMed] [Google Scholar]
  11. Deuel T. F., Senior R. M., Chang D., Griffin G. L., Heinrikson R. L., Kaiser E. T. Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4584–4587. doi: 10.1073/pnas.78.7.4584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Deuel T. F., Senior R. M., Huang J. S., Griffin G. L. Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J Clin Invest. 1982 Apr;69(4):1046–1049. doi: 10.1172/JCI110509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dhillon A. P., Anthony A., Sim R., Wakefield A. J., Sankey E. A., Hudson M., Allison M. C., Pounder R. E. Mucosal capillary thrombi in rectal biopsies. Histopathology. 1992 Aug;21(2):127–133. doi: 10.1111/j.1365-2559.1992.tb00360.x. [DOI] [PubMed] [Google Scholar]
  14. Dickinson C. J., Martin J. F. Megakaryocytes and platelet clumps as the cause of finger clubbing. Lancet. 1987 Dec 19;2(8573):1434–1435. doi: 10.1016/s0140-6736(87)91132-9. [DOI] [PubMed] [Google Scholar]
  15. Donnellan W. L. Early histological changes in ulcerative colitis. A light and electron microscopic study. Gastroenterology. 1966 Apr;50(4):519–540. [PubMed] [Google Scholar]
  16. Eliakim R., Karmeli F., Razin E., Rachmilewitz D. Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone. Gastroenterology. 1988 Nov;95(5):1167–1172. doi: 10.1016/0016-5085(88)90346-0. [DOI] [PubMed] [Google Scholar]
  17. Elwood P. C., Renaud S., Sharp D. S., Beswick A. D., O'Brien J. R., Yarnell J. W. Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study. Circulation. 1991 Jan;83(1):38–44. doi: 10.1161/01.cir.83.1.38. [DOI] [PubMed] [Google Scholar]
  18. Fairburn R. A. On the aetiology of ulcerative colitis. A vascular hypothesis. Lancet. 1973 Mar 31;1(7805):697–699. doi: 10.1016/s0140-6736(73)91482-7. [DOI] [PubMed] [Google Scholar]
  19. Goetzl E. J., Woods J. M., Gorman R. R. Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid. J Clin Invest. 1977 Jan;59(1):179–183. doi: 10.1172/JCI108617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Greenfield S. M., Punchard N. A., Teare J. P., Thompson R. P. Review article: the mode of action of the aminosalicylates in inflammatory bowel disease. Aliment Pharmacol Ther. 1993 Aug;7(4):369–383. doi: 10.1111/j.1365-2036.1993.tb00110.x. [DOI] [PubMed] [Google Scholar]
  21. Harries A. D., Fitzsimons E., Fifield R., Dew M. J., Rhoades J. Platelet count: a simple measure of activity in Crohn's disease. Br Med J (Clin Res Ed) 1983 May 7;286(6376):1476–1476. doi: 10.1136/bmj.286.6376.1476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Janka H. U., Standl E., Schramm W., Mehnert H. Platelet enzyme activities in diabetes mellitus in relation to endothelial damage. Diabetes. 1983 May;32 (Suppl 2):47–51. doi: 10.2337/diab.32.2.s47. [DOI] [PubMed] [Google Scholar]
  23. Kaplan K. L., Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood. 1981 Feb;57(2):199–202. [PubMed] [Google Scholar]
  24. Kaplanski G., Porat R., Aiura K., Erban J. K., Gelfand J. A., Dinarello C. A. Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. Blood. 1993 May 15;81(10):2492–2495. [PubMed] [Google Scholar]
  25. Kaufmann H. J., Taubin H. L. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann Intern Med. 1987 Oct;107(4):513–516. doi: 10.7326/0003-4819-107-4-513. [DOI] [PubMed] [Google Scholar]
  26. Knot E., Ten Cate J. W., Leeksma O. C., Tytgat G. N., Vreeken J. No evidence for a prethrombotic state in stable chronic inflammatory bowel disease. J Clin Pathol. 1983 Dec;36(12):1387–1390. doi: 10.1136/jcp.36.12.1387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lake A. M., Stauffer J. Q., Stuart M. J. Hemostatic alterations in inflammatory bowel disease: response to therapy. Am J Dig Dis. 1978 Oct;23(10):897–902. doi: 10.1007/BF01072463. [DOI] [PubMed] [Google Scholar]
  28. Larsen E., Celi A., Gilbert G. E., Furie B. C., Erban J. K., Bonfanti R., Wagner D. D., Furie B. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell. 1989 Oct 20;59(2):305–312. doi: 10.1016/0092-8674(89)90292-4. [DOI] [PubMed] [Google Scholar]
  29. Levin J., Bessman J. D. The inverse relation between platelet volume and platelet number. Abnormalities in hematologic disease and evidence that platelet size does not correlate with platelet age. J Lab Clin Med. 1983 Feb;101(2):295–307. [PubMed] [Google Scholar]
  30. Lorenzet R., Niemetz J., Marcus A. J., Broekman M. J. Enhancement of mononuclear procoagulant activity by platelet 12-hydroxyeicosatetraenoic acid. J Clin Invest. 1986 Aug;78(2):418–423. doi: 10.1172/JCI112592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Maclouf J., Fitzpatrick F. A., Murphy R. C. Transcellular biosynthesis of eicosanoids. Pharmacol Res. 1989 Jan-Feb;21(1):1–7. doi: 10.1016/1043-6618(89)90115-1. [DOI] [PubMed] [Google Scholar]
  32. Mahida Y. R., Kurlac L., Gallagher A., Hawkey C. J. High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. Gut. 1991 Dec;32(12):1531–1534. doi: 10.1136/gut.32.12.1531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Martin J. F., Bath P. M., Burr M. L. Influence of platelet size on outcome after myocardial infarction. Lancet. 1991 Dec 7;338(8780):1409–1411. doi: 10.1016/0140-6736(91)92719-i. [DOI] [PubMed] [Google Scholar]
  34. Martin J. F., Trowbridge E. A., Salmon G., Plumb J. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res. 1983 Dec 1;32(5):443–460. doi: 10.1016/0049-3848(83)90255-4. [DOI] [PubMed] [Google Scholar]
  35. Mori K., Watanabe H., Hiwatashi N., Sugai K., Goto Y. Studies on blood coagulation in ulcerative colitis and Crohn's disease. Tohoku J Exp Med. 1980 Sep;132(1):93–101. doi: 10.1620/tjem.132.93. [DOI] [PubMed] [Google Scholar]
  36. Palabrica T., Lobb R., Furie B. C., Aronovitz M., Benjamin C., Hsu Y. M., Sajer S. A., Furie B. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature. 1992 Oct 29;359(6398):848–851. doi: 10.1038/359848a0. [DOI] [PubMed] [Google Scholar]
  37. Rampton D. S. Non-steroidal anti-inflammatory drugs and the lower gastrointestinal tract. Scand J Gastroenterol. 1987 Jan;22(1):1–4. doi: 10.3109/00365528708991847. [DOI] [PubMed] [Google Scholar]
  38. Ranger S., Martin P., Roussanne M. C., Denis F. Prevalence of hepatitis C virus antibodies in the general population and in selected groups of patients in Limoges, France. Gut. 1993;34(2 Suppl):S50–S51. doi: 10.1136/gut.34.2_suppl.s50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Ross R., Raines E. W., Bowen-Pope D. F. The biology of platelet-derived growth factor. Cell. 1986 Jul 18;46(2):155–169. doi: 10.1016/0092-8674(86)90733-6. [DOI] [PubMed] [Google Scholar]
  40. Schwartz B. S., Monroe M. C. Human platelet aggregation is initiated by peripheral blood mononuclear cells exposed to bacterial lipopolysaccharide in vitro. J Clin Invest. 1986 Nov;78(5):1136–1141. doi: 10.1172/JCI112693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Shah A., Morgan G., Rose J. D., Fifield R., Rhodes J. Platelet number and size in relation to serum orosomucoid concentration in Crohn's disease. Med Lab Sci. 1989 Jan;46(1):79–80. [PubMed] [Google Scholar]
  42. Simi M., Leardi S., Tebano M. T., Castelli M., Costantini F. M., Speranza V. Raised plasma concentrations of platelet factor 4 (PF4) in Crohn's disease. Gut. 1987 Mar;28(3):336–338. doi: 10.1136/gut.28.3.336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Stevens T. R., James J. P., Simmonds N. J., McCarthy D. A., Laurenson I. F., Maddison P. J., Rampton D. S. Circulating von Willebrand factor in inflammatory bowel disease. Gut. 1992 Apr;33(4):502–506. doi: 10.1136/gut.33.4.502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Talstad I., Rootwelt K., Gjone E. Thrombocytosis in ulcerative colitis and Crohn's disease. Scand J Gastroenterol. 1973;8(2):135–138. [PubMed] [Google Scholar]
  45. Thompson C. B., Jakubowski J. A., Quinn P. G., Deykin D., Valeri C. R. Platelet size and age determine platelet function independently. Blood. 1984 Jun;63(6):1372–1375. [PubMed] [Google Scholar]
  46. Thompson C. B., Love D. G., Quinn P. G., Valeri C. R. Platelet size does not correlate with platelet age. Blood. 1983 Aug;62(2):487–494. [PubMed] [Google Scholar]
  47. Trip M. D., Cats V. M., van Capelle F. J., Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med. 1990 May 31;322(22):1549–1554. doi: 10.1056/NEJM199005313222201. [DOI] [PubMed] [Google Scholar]
  48. Trowbridge E. A., Reardon D. M., Hutchinson D., Pickering C. The routine measurement of platelet volume: a comparison of light-scattering and aperture-impedance technologies. Clin Phys Physiol Meas. 1985 Aug;6(3):221–238. doi: 10.1088/0143-0815/6/3/003. [DOI] [PubMed] [Google Scholar]
  49. Tschoepe D., Roesen P., Esser J., Schwippert B., Nieuwenhuis H. K., Kehrel B., Gries F. A. Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost. 1991 Oct;17(4):433–438. doi: 10.1055/s-2007-1002650. [DOI] [PubMed] [Google Scholar]
  50. Vilaseca J., Salas A., Guarner F., Rodriguez R., Malagelada J. R. Participation of thromboxane and other eicosanoid synthesis in the course of experimental inflammatory colitis. Gastroenterology. 1990 Feb;98(2):269–277. doi: 10.1016/0016-5085(90)90814-h. [DOI] [PubMed] [Google Scholar]
  51. Visser M. R., Tracy P. B., Vercellotti G. M., Goodman J. L., White J. G., Jacob H. S. Enhanced thrombin generation and platelet binding on herpes simplex virus-infected endothelium. Proc Natl Acad Sci U S A. 1988 Nov;85(21):8227–8230. doi: 10.1073/pnas.85.21.8227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Wakefield A. J., Pittilo R. M., Sim R., Cosby S. L., Stephenson J. R., Dhillon A. P., Pounder R. E. Evidence of persistent measles virus infection in Crohn's disease. J Med Virol. 1993 Apr;39(4):345–353. doi: 10.1002/jmv.1890390415. [DOI] [PubMed] [Google Scholar]
  53. Wakefield A. J., Sawyerr A. M., Dhillon A. P., Pittilo R. M., Rowles P. M., Lewis A. A., Pounder R. E. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet. 1989 Nov 4;2(8671):1057–1062. doi: 10.1016/s0140-6736(89)91078-7. [DOI] [PubMed] [Google Scholar]
  54. Webberley M. J., Hart M. T., Melikian V. Thromboembolism in inflammatory bowel disease: role of platelets. Gut. 1993 Feb;34(2):247–251. doi: 10.1136/gut.34.2.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Wellmann W., Fink P. C., Benner F., Schmidt F. W. Endotoxaemia in active Crohn's disease. Treatment with whole gut irrigation and 5-aminosalicylic acid. Gut. 1986 Jul;27(7):814–820. doi: 10.1136/gut.27.7.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. van Wersch J. W., Houben P., Rijken J. Platelet count, platelet function, coagulation activity and fibrinolysis in the acute phase of inflammatory bowel disease. J Clin Chem Clin Biochem. 1990 Aug;28(8):513–517. doi: 10.1515/cclm.1990.28.8.513. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES